Antifungal Selection for the Treatment of Onychomycosis: Patient Considerations and Outcomes.
Journal Information
Full Title: Infect Drug Resist
Abbreviation: Infect Drug Resist
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure Eden Axler reports no conflicts of interest in this work. Dr Shari Lipner reports grants from Moberg Pharmaceuticals, Belle Torus Corporation; personal fees from Hoth Therapeutics, Ortho Dermatologics, and Eli Lilly, outside the submitted work. Dr. Lipner has also served as a consultant for Ortho-Dermatologics, Eli Lilly, Moberg Pharmaceuticals, and BelleTorus Corporation."
"No funding was utilized in the preparation of this manuscript."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025